These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 24354262)
1. [Comparison of visual acuity and central macular thickness after vitrectomy for diffuse diabetic macular edema with or without preoperative treatments]. Nizawa T; Arai M; Takatsuna Y; Oshitari T; Sato E; Yamamoto S Nippon Ganka Gakkai Zasshi; 2013 Oct; 117(10):785-92. PubMed ID: 24354262 [TBL] [Abstract][Full Text] [Related]
2. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone]. Naser H; Koss MJ; Singh P; Koch F Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827 [TBL] [Abstract][Full Text] [Related]
3. [Pars plana vitrectomy and combination therapy pars plana vitrectomy, intravitreal triamcinolon acetonid and macular lasercoagulation - one year results]. Stefaničková J; Strmeň P; Vavrová K; Mrózová L; Krásnik V Cesk Slov Oftalmol; 2012 Nov; 68(5):180-8. PubMed ID: 23461369 [TBL] [Abstract][Full Text] [Related]
4. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema. Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632 [TBL] [Abstract][Full Text] [Related]
5. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract. Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251 [TBL] [Abstract][Full Text] [Related]
6. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema. Kang SW; Park SC; Cho HY; Kang JH Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema. Solaiman KA; Diab MM; Abo-Elenin M Retina; 2010; 30(10):1638-45. PubMed ID: 20838357 [TBL] [Abstract][Full Text] [Related]
8. Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema. A prospective, randomized comparative study. Raizada S; Al Kandari J; Al Diab F; Al Sabah K; Kumar N; Mathew S Indian J Ophthalmol; 2015 Jun; 63(6):504-10. PubMed ID: 26265641 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA Retina; 2007; 27(9):1187-95. PubMed ID: 18046223 [TBL] [Abstract][Full Text] [Related]
10. Initial macular thickness and response to treatment in diabetic macular edema. Soheilian M; Ramezani A; Yaseri M; Mirdehghan SA; Obudi A; Bijanzadeh B Retina; 2011 Sep; 31(8):1564-73. PubMed ID: 21451442 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes. Doi N; Sakamoto T; Sonoda Y; Yasuda M; Yonemoto K; Arimura N; Uchino E; Ishibashi T Graefes Arch Clin Exp Ophthalmol; 2012 Jan; 250(1):71-8. PubMed ID: 21853229 [TBL] [Abstract][Full Text] [Related]
12. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion. Sonoda Y; Arimura N; Shimura M; Sakamoto T Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366 [TBL] [Abstract][Full Text] [Related]
13. Results of visual acuity and foveal thickness in diabetic macular edema after vitrectomy. Shimonagano Y; Makiuchi R; Miyazaki M; Doi N; Uemura A; Sakamoto T Jpn J Ophthalmol; 2007; 51(3):204-9. PubMed ID: 17554483 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application. Browning DJ; Fraser CM; Powers ME Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema. Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127 [TBL] [Abstract][Full Text] [Related]
16. [Triamcinolone in the treatment of the diabetic macular edema--one-year results]. Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654 [TBL] [Abstract][Full Text] [Related]
17. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation. Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140 [TBL] [Abstract][Full Text] [Related]
19. [Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study]. Arévalo JF; Fernández CF; Mendoza AJ; García RA; Arévalo FA Arch Soc Esp Oftalmol; 2013 Oct; 88(10):373-9. PubMed ID: 24060300 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion]. Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]